We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-8.62%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$902M
AUM Growth
-$613M
(-40%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-45.55%
Top 10 Holdings %
Top 10 Hldgs %
57.67%
Holding
342
New
42
Increased
40
Reduced
54
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amneal Pharmaceuticals
AMRX
|
+$6.87M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.2M |
| 3 |
TSMC
TSM
|
+$1.88M |
| 4 |
Booking.com
BKNG
|
+$1.49M |
| 5 |
Wheaton Precious Metals
WPM
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DigitalBridge
DBRG
|
+$33.8M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$23.1M |
| 3 |
Incyte
INCY
|
+$10.1M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$9.75M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$9.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.66% |
| 2 | Industrials | 5.91% |
| 3 | Financials | 5.49% |
| 4 | Technology | 5.04% |
| 5 | Communication Services | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SINA
1
DELISTED
Sina Corp
SINA
| $75.8M | 8.41% |
1,935,332
-24,734
| -1% | -$1.01M |
|
|
2
Amneal Pharmaceuticals
AMRX
$5.59B
| $62.4M | 6.92% |
21,521,301
+1,969,300
| +10% | +$6.87M |
|
|
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
| $47.8M | 5.3% |
16,471,258
+1,000
| +0% | +$5.92K |
|
|
BEST
4
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $35M | 3.88% |
331,701
-13,345
| -4% | -$1.33M |
|
5
Nature's Sunshine
NATR
$369M
| $23.7M | 2.62% |
2,854,607
| – | – |
|
6
Gilead Sciences
GILD
$165B
| $21.5M | 2.38% |
339,003
-65,970
| -16% | -$4.31M |
|
7
Verrica Pharmaceuticals
VRCA
$94.3M
| $11.7M | 1.29% |
79,141
-287
| -0.4% | -$32K |
|
8
Brookfield Renewable
BEP
$9.72B
| $8.35M | 0.93% |
225,180
| – | – |
|
|
CIH
9
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $8.25M | 0.91% |
2,115,228
-1,071,271
| -34% | -$3.45M |
|
|
SFUN
10
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $7.3M | 0.81% |
328,621
+5,004
| +2% | +$110K |
|
11
Brookfield
BN
$104B
| $6.74M | 0.75% |
350,342
-5,605
| -2% | -$101K |
|
12
Deutsche Bank
DB
$66.4B
| $6.62M | 0.73% |
873,000
+12,000
| +1% | +$91.3K |
|
|
13
Booking.com
BKNG
$139B
| $6.38M | 0.71% |
82,000
+19,250
| +31% | +$1.49M |
|
|
RVNC
14
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.14M | 0.68% |
472,532
| – | – |
|
15
Alphabet (Google) Class A
GOOGL
$4.3T
| $5.29M | 0.59% |
86,380
-20
| -0% | -$1.18K |
|
|
BBU
16
DELISTED
Brookfield Business Partners
BBU
| $5.14M | 0.57% |
148,836
+15,580
| +12% | +$370K |
|
17
Amazon
AMZN
$2.69T
| $4.93M | 0.55% |
57,180
+5,800
| +11% | +$538K |
|
|
SOHU
18
Sohu.com
SOHU
$346M
| $4.9M | 0.54% |
482,014
-593,981
| -55% | -$6.99M |
|
19
Visa
V
$686B
| $4.47M | 0.5% |
25,700
+2,560
| +11% | +$456K |
|
|
HARP
20
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $4.42M | 0.49% |
32,340
| – | – |
|
21
MakeMyTrip
MMYT
$5.05B
| $4.24M | 0.47% |
186,867
-22,518
| -11% | -$553K |
|
22
Mastercard
MA
$484B
| $4.18M | 0.46% |
15,550
-1,090
| -7% | -$300K |
|
23
Meta Platforms (Facebook)
META
$1.64T
| $4.09M | 0.45% |
23,110
-938
| -4% | -$178K |
|
|
CBAY
24
DELISTED
Cymabay Therapeutics
CBAY
| $3.93M | 0.44% |
768,142
-65,954
| -8% | -$399K |
|
25
Medtronic
MDT
$107B
| $3.84M | 0.43% |
35,800
+4,610
| +15% | +$481K |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
LWPC
MHC
Fosun International's Q3 2019 Portfolio in Review
As of Q3 2019, Fosun International held 342 positions worth $902M, down 40% from $1.51B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Fosun International withdrew a net $411M in Q3 2019, closing 115 positions and reducing 54 holdings. Its most notable exit was DigitalBridge, an estimated $33.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 32% a quarter earlier, followed by Industrials and Financials.
Against the trend, Fosun International opened a new position in Zoetis worth $1.24M.
- Fosun International's largest Q3 2019 buy was Zoetis: 10,000 shares worth $1.24M.
- Fosun International added most to Amneal Pharmaceuticals in Q3 2019, an estimated $6.87M increase.
- Fosun International's biggest Q3 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.14M.
- Fosun International fully exited DigitalBridge in Q3 2019, selling an estimated $33.8M.
- Fosun International's ten largest holdings make up 58% of its $902M portfolio in Q3 2019.
- Fosun International opened 42 new positions and closed 115 in Q3 2019.
- Fosun International's portfolio value fell 40% quarter-over-quarter to $902M.
Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.